Novel antibiotic candidates starve resistant bacteria by blocking vitamin supply

Bacteria have spent decades evolving resistance to virtually every antibiotic we have thrown at them. To stay ahead, new drugs must hit targets that existing antibiotics have never touched. The science-journalism coverage adds useful context, while the strongest evidential footing still comes from the underlying data, papers or institutional documentation.

The significance lies in chemistry gains force when a claimed structure or process can be described with enough precision to be reproduced by others. Synthetic routes, spectroscopic signatures, yield under defined conditions and stability under realistic operating parameters are the currency of credibility in chemistry, and a result that lacks these details cannot be evaluated independently. The distance between a discovery on a laboratory bench and a process that works reliably at scale is measured in years of optimization, and each step reveals constraints that were invisible at smaller scale. The team published its findings in two studies in the Journal of Medicinal Chemistry. By Andreas Fischer, Helmholtz Association of German Research Centres This article has been reviewed according to Science X's editorial process and policies.

To stay ahead, new drugs must hit targets that existing antibiotics have never touched. Unlike humans, many bacteria rely on specialized membrane transporters, called energy-coupling factor transporters, or ECF transporters, to actively and efficiently import.

In the first study, the researchers synthesized a large number of variants of the original molecule and systematically assessed their pharmaceutical properties. The researchers also demonstrated that the new generation of molecules can successfully combat bacterial infections in insect and zebrafish larvae, providing the first.

A study published simultaneously tackled a more fundamental question: Can bacteria find an alternative route to import the vitamins they need if the transporter is blocked. Eleonora Diamanti, first author of the second publication.

The broader interest lies in whether the claimed property or reaction pathway can be characterized with enough precision to support replication by other groups. Chemistry has a replication problem that is less discussed than the one in psychology or medicine, but it is real: synthetic procedures that work reliably in one laboratory sometimes fail to transfer, for reasons ranging from impure starting materials to undocumented temperature sensitivities. A result that comes with full experimental detail and a clear characterization of the product is far more valuable than one that reports a discovery without the procedural backbone.

Together, the two studies provide the first evidence that ECF transporters are a viable and druggable target for the development of new antibiotics. Ioulia Exapicheidou et al, Hit-to-Lead Optimization of Energy-Coupling Factor (ECF) Transporter Inhibitors as Novel Antibiotic, Journal of Medicinal Chemistry (2026).

Because this item comes through Phys. org Chemistry as science journalism, it should be treated as contextual reporting rather than primary evidence. Good science reporting can identify why a result matters, connect it to the wider literature and make technical work readable, but the decisive evidence remains in the original paper, dataset, mission release or technical record. That distinction is especially important when a story is later repeated by aggregators, because repetition increases visibility, not evidential strength.

The next step is to see whether independent groups working with orthogonal techniques reach compatible conclusions, and whether the result scales beyond the conditions used in the original study. Chemical discoveries that matter tend to be ones whose key properties can be measured by multiple spectroscopic, crystallographic or computational methods that are unlikely to share the same blind spots. Scalability, cost and long-term stability under realistic operating conditions are additional filters that come into play before any practical application becomes viable.

Source